117 related articles for article (PubMed ID: 2324541)
1. Risk of Haemophilus influenzae type b disease in children with cancer and response of immunocompromised leukemic children to a conjugate vaccine.
Feldman S; Gigliotti F; Shenep JL; Roberson PK; Lott L
J Infect Dis; 1990 May; 161(5):926-31. PubMed ID: 2324541
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of Haemophilus b conjugate vaccine (meningococcal protein conjugate) in children with prior invasive Haemophilus influenzae type b disease.
Walter EB; Moggio MV; Drucker RP; Wilfert CM
Pediatr Infect Dis J; 1990 Sep; 9(9):632-5. PubMed ID: 2235187
[TBL] [Abstract][Full Text] [Related]
3. Immunization of leukemic children with Haemophilus conjugate vaccine.
Lange B; Jakacki R; Nasab AH; Luery N; McVerry PH
Pediatr Infect Dis J; 1989 Dec; 8(12):883-4. PubMed ID: 2626288
[No Abstract] [Full Text] [Related]
4. Immunoglobulin deficiency and idiotype expression in children developing Haemophilus influenzae type b disease after vaccination with conjugate vaccine. The Collaborative Study Group.
Holmes SJ; Lucas AH; Osterholm MT; Froeschle JE; Granoff DM
JAMA; 1991 Oct; 266(14):1960-5. PubMed ID: 1895474
[TBL] [Abstract][Full Text] [Related]
5. Antibody response to immunization with Haemophilus influenzae type b polysaccharide vaccine in children with cancer.
Weisman SJ; Cates KL; Allegretta GJ; Quinn JJ; Altman AJ
J Pediatr; 1987 Nov; 111(5):727-9. PubMed ID: 3499501
[No Abstract] [Full Text] [Related]
6. The biology of Haemophilus influenzae type b vaccination failure.
Holmes SJ; Granoff DM
J Infect Dis; 1992 Jun; 165 Suppl 1():S121-8. PubMed ID: 1588145
[TBL] [Abstract][Full Text] [Related]
7. Prevention of Haemophilus influenzae type b infections in Apache and Navajo children.
Santosham M; Rivin B; Wolff M; Reid R; Newcomer W; Letson GW; Almeido-Hill J; Thompson C; Siber GR
J Infect Dis; 1992 Jun; 165 Suppl 1():S144-51. PubMed ID: 1588150
[TBL] [Abstract][Full Text] [Related]
8. In vitro induction of IgG1 and IgG2 secretion by B cells of children who developed invasive haemophilus disease despite vaccination.
Chacko A; Granoff DM
Pediatr Res; 1991 Jul; 30(1):124-9. PubMed ID: 1891277
[TBL] [Abstract][Full Text] [Related]
9. National Advisory Committee on Immunization (NACI). Statement on Haemophilus influenzae type B conjugate vaccines for use in infants and children.
Can Commun Dis Rep; 1992 Dec; 18(23):169-76. PubMed ID: 1291012
[TBL] [Abstract][Full Text] [Related]
10. Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody.
Lee YC; Kelly DF; Yu LM; Slack MP; Booy R; Heath PT; Siegrist CA; Moxon RE; Pollard AJ
Clin Infect Dis; 2008 Jan; 46(2):186-92. PubMed ID: 18171249
[TBL] [Abstract][Full Text] [Related]
11. Response of human immunodeficiency virus-exposed and -infected infants to Haemophilus influenzae type b conjugate vaccine.
Rutstein RM; Rudy BJ; Cnaan A
Arch Pediatr Adolesc Med; 1996 Aug; 150(8):838-41. PubMed ID: 8704891
[TBL] [Abstract][Full Text] [Related]
12. Immunization with Haemophilus influenzae type b polysaccharide vaccine at 18 and 24 months of age: evidence of decreased immunogenicity.
Adderson EE; Chisholm N; Halperin SA
Clin Invest Med; 1991 Aug; 14(4):338-45. PubMed ID: 1782732
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of a fourth dose of Haemophilus influenzae type b (Hib) conjugate vaccine and antibody persistence in young children from the United Kingdom who were primed with acellular or whole-cell pertussis component-containing Hib combinations in infancy.
Southern J; McVernon J; Gelb D; Andrews N; Morris R; Crowley-Luke A; Goldblatt D; Miller E
Clin Vaccine Immunol; 2007 Oct; 14(10):1328-33. PubMed ID: 17699835
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease.
Siber GR; Thompson C; Reid GR; Almeido-Hill J; Zacher B; Wolff M; Santosham M
J Infect Dis; 1992 Jun; 165 Suppl 1():S129-33. PubMed ID: 1588146
[TBL] [Abstract][Full Text] [Related]
15. Opsonophagocidal activity in sera from infants and children immunized with Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate).
Gray BM
Pediatrics; 1990 Apr; 85(4 Pt 2):694-7. PubMed ID: 2107521
[TBL] [Abstract][Full Text] [Related]
16. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.
Sood SK; Daum RS
Pediatrics; 1990 Apr; 85(4 Pt 2):698-704. PubMed ID: 2107522
[TBL] [Abstract][Full Text] [Related]
17. Persistence of antibody and booster responses to reimmunization with Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children initially immunized at 15 to 24 months of age.
Berkowitz CD; Ward JI; Chiu CE; Marcy SM; Gordon L; Hendley JO; Meier K; Marchant CD; McVerry P
Pediatrics; 1990 Mar; 85(3):288-93. PubMed ID: 2304781
[TBL] [Abstract][Full Text] [Related]
18. Haemophilus influenzae type b: the search for a vaccine.
Robbins JB; Schneerson R
Pediatr Infect Dis J; 1987 Aug; 6(8):791-4. PubMed ID: 3313243
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and reactogenicity of Haemophilus influenzae type b-meningococcus group B outer membrane protein conjugate vaccine in children 2-60 months of age.
Shehab ZM; Azimi P; Asmar BI; Dunphy MG; Ayoub EM; Dajani AS
Scand J Infect Dis; 1991; 23(6):763-9. PubMed ID: 1815340
[TBL] [Abstract][Full Text] [Related]
20. A major crossreactive idiotype associated with human antibodies to the Haemophilus influenzae b polysaccharide. Expression in relation to age and immunoglobulin G subclass.
Lucas AH; Granoff DM
J Clin Invest; 1990 Apr; 85(4):1158-66. PubMed ID: 2318971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
